{"id":"drug-syha1805-tablets","_chembl":{"chemblId":"CHEMBL157030","moleculeType":"Small molecule","molecularWeight":"883.99"},"modality":"Small molecule","_dailymed":null,"_scrapedAt":"2026-03-28T05:03:05.004Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_claudeStub":{"ts":1779123436,"model":"claude-sonnet-4-5-20250929"},"description":"SYHA1805 is an investigational oral tablet in Phase 1 clinical development by CSPC ZhongQi Pharmaceutical Technology Co., Ltd. The drug's molecular target, mechanism of action, and therapeutic indication have not been publicly disclosed. As an early-stage candidate, safety and efficacy data are limited.","indications":{"approved":[{"status":"investigational","condition":null,"patientPopulation":null}]},"trialDetails":[{"nctId":"NCT04645901","phase":"PHASE1","title":"A Study of SYHA1805 in Healthy Adult Subjects","status":"UNKNOWN","sponsor":"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.","startDate":"2020-12","conditions":"Healthy Subjects","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":29982,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"Drug: SYHA1805 tablets","genericName":"Drug: SYHA1805 tablets","companyName":"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.","companyId":"cspc-zhongqi-pharmaceutical-technology-co-ltd","firstApprovalDate":"","aiSummary":"","enrichmentLevel":1,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}